🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Worries

However, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users administering substances of unknown origin.

Some experts said the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking fines, prosecution or prison.

Service Reaction and Material Elimination

Based on the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The organization stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also discovered groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, positive reviews and detailed instructions for preparing or injecting at residence.

Within minutes of entering one group, a seller posted contact information, where most purchases occur. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these communities, messages show dark colored parcels with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram said it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her staff has previously seen patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially significant health risks”.